Delivery Order SPE2DB20D1100-SPE2DB24FD1W4

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity (a medication used to treat type 2 diabetes) to the Defense Logistics Agency (DLA). The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,805.60 firm-fixed-price delivery order is for the supply of Trulicity, a medication used to treat type 2 diabetes. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. The IDC enables the DLA to efficiently procure a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $2,902.80 firm-fixed-price delivery order is for the supply of the prescription drug Trulicity, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trulicity pharmaceutical products, a medication used for the treatment of diabetes. The contract, valued at $1,741.68, was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of July 22, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award, valued at $2,102.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity, a diabetes medication, with an ultimate completion date of April 24, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger...
This federal contract award, valued at $1,380.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Trulicity, a diabetes medication, with a performance period through May 2025. This contract is not set aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,501.50 Firm Fixed Price Delivery Order is for the provision of the drug Trulicity, a medication used to manage diabetes. The contract has an ultimate completion date of December 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity, a prescription medication for diabetes management. The $19,940.72 firm fixed-price delivery order falls under a broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award, valued at $3,010.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity, a medication used to treat type 2 diabetes, with a completion date of October 19, 2021. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at...
This federal contract award, valued at $1,351.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Trulicity, a diabetes medication, under a Firm Fixed Price contract type. The contract has an ultimate completion date of April 24, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD1W4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity, a medication used to treat type 2 diabetes. The firm-fixed-price delivery order, valued at $1,390.44, has an ultimate completion date of August 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, that enables the agency to efficiently procure a wide range of medical commodities, including prescription drugs and other essential pharmaceutical products, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/7/24, 9:22 AM